are leaving our market, so far there has been only one drug that has left - this is saldenafil, the phizer company, well, in other words, viagra well, the first one, first, there are many analogues. secondly, i think we can manage without him. well, yes, that's why here we have, uh, in general, more optimism than pessimism. second. this means that individual specific trade names may disappear or disappear. it is tied to the so-called international or proprietary name, that is, to the active substance that has a therapeutic effect, we are increasing the production of drugs with these mns within the country, if there are opportunities for this, and in general we are moving away from the term about imported, because what, in principle, we perceive it as our own, because these are the jobs, these taxes that remain here and here , the most important thing is the products and the same companies that i mentioned. today, they probably face the same problems as companies with 100% russian capital. claims of the problem, when the ingredients are delivered here , it is easier to deliver medicines to